Clinical Pharmacology Lead
Boehringer Ingelheim Pharmaceuticals, Inc., New Jersey
Fenglei Huang, PhD. FCP, is the Director and Team Lead of Clinical Pharmacology at Boehringer Ingelheim, where he also chairs the Drug-Drug Interaction Expert Group. With a Ph.D. in Pharmaceutical Science from the University of Florida, he is an elected fellow of the American College of Clinical Pharmacology (ACCP). He has made notable contributions to the field, co-authoring over 40 peer-reviewed scientific articles, and presenting at over 60 national and international conferences.
Disclosure information not submitted.
Rapid Fires: Challenges and Opportunities Associated with Targeted Therapeutics
Tuesday, October 22, 2024
3:00 PM – 4:00 PM MT